KPC Pharmaceuticals,Inc reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 1,852.64 million compared to CNY 1,910.05 million a year ago. Revenue was CNY 1,852.64 million compared to CNY 1,910.05 million a year ago.

Net income was CNY 118.69 million compared to CNY 131.03 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.17 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.17 a year ago.